OssDsign - Q4 suggests financial estimates revisions
2022-02-23 10:00:00
Redeye returns with a more detailed take on the Q4’21 report. We lower our sales estimates considerably more than initially expected while also upping certain costs. This renders a new fair value range.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/